SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (46)6/13/2001 2:30:36 PM
From: tuck  Read Replies (2) of 1005
 
Stefaan, in consultation with an anesthesiologist friend, offers some thoughts on PTIE. Thanks, fellas!

>>1/ very big market
2/ However you're not going to counter addiction and tolerance.
3/ There is already such a product on the market (valtran) Problem is that above a certain dose upping the dose doesn't give any benefit.
4/ Opiates have 2 major side effects:
constipation, dose related; and permanent
nausea, temporary.
So one could alleviate only constipation.
5/ Problem is that there is a fairly wide variance in individual response to nalaxone.

Stefaan closes by saying he's not super optimistic about the stock and has only a small position, but knows "very intelligent people" who are also looking at it.

If I misquoted anybody, stefaan, speak up.

My trigger finger is getting itchy on DPII. Within 1/4 point of target. MCLS news is nice and it's good to see the stock hold up. It is not the news I am looking for: deals. Holding on in spite of enormous temptation to book a big one.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext